Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

about

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

Item

http://www.wikidata.org/entity/Q49829601

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@en

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@nl

type

Item

label

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@en

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@nl

prefLabel

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@en

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@nl

P1476

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

@en

P2093

Rogerio Panizzutti

http://www.w3.org/2001/XMLSchema#string

P2860

Ketamine and other glutamate receptor modulators for depression in adults

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes

D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor

Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Aging and Speech Understanding.

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

D-serine added to clozapine for the treatment of schizophrenia

Glia-derived D-serine controls NMDA receptor activity and synaptic memory

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPSYT.2018.00014

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

G D Guercio

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29459833

http://www.w3.org/2001/XMLSchema#string

P932

5807334

http://www.w3.org/2001/XMLSchema#string